We are live on ! Find out more
AEMD icon

Aethlon Medical

14 hedge funds and large institutions have $1.51M invested in Aethlon Medical in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

54% more capital invested

Capital invested by funds: $975K → $1.51M (+$531K)

27% more funds holding

Funds holding: 1114 (+3)

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q1 2018 in Review

14 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2018, worth a combined $1.51M — up 54% from $975K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new AEMD positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $301K. The largest seller was Bank of America, exiting entirely with an estimated $17.7K sold.

  • 14 institutional investors held Aethlon Medical (AEMD) as of Q1 2018, up from 11 in Q4 2017.
  • Funds reported $1.51M of Aethlon Medical stock for Q1 2018, up 54% quarter-over-quarter.
  • 4 funds opened new Aethlon Medical positions in Q1 2018 and 1 closed out, a net change of +3 holders.
  • The largest Aethlon Medical buyer in Q1 2018 was Millennium Management, an estimated $301K added.
  • The largest Aethlon Medical seller in Q1 2018 was Bank of America, an estimated $17.7K sold.

Based on aggregated 13F filings for Q1 2018.